Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Long-Term Mortality in Patients with Positive Lymph Nodes at the Time of Radical Prostatectomy.

Froehner M, Koch R, Farahzadi S, Heberling U, Borkowetz A, Twelker L, Baretton GB, Wirth MP, Thomas C.

Urol Int. 2019;103(4):427-432. doi: 10.1159/000500961. Epub 2019 Oct 29.

2.

Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database.

Schiavina R, Bianchi L, Borghesi M, Briganti A, Brunocilla E, Carini M, Terrone C, Mottrie A, Dente D, Gacci M, Gontero P, Gurioli A, Imbimbo C, La Manna G, Marchioro G, Milanese G, Mirone V, Montorsi F, Morgia G, Munegato S, Novara G, Panarello D, Porreca A, Russo GI, Serni S, Simonato A, Urzì D, Verze P, Volpe A, Martorana G.

Int J Urol. 2016 Dec;23(12):1000-1008. doi: 10.1111/iju.13203. Epub 2016 Sep 12.

3.

The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.

Bianchi L, Nini A, Bianchi M, Gandaglia G, Fossati N, Suardi N, Moschini M, Dell'Oglio P, Schiavina R, Montorsi F, Briganti A.

Eur Urol. 2016 Jun;69(6):1142-8. doi: 10.1016/j.eururo.2015.12.010. Epub 2015 Dec 31.

PMID:
26749093
4.

Number of metastatic lymph nodes as determinant of outcome after salvage radical prostatectomy for radiation-recurrent prostate cancer.

Gugliemetti G, Sukhu R, Conca Baenas MA, Meeks J, Sjoberg DD, Eastham JA, Scardino PT, Touijer K.

Actas Urol Esp. 2016 Sep;40(7):434-9. doi: 10.1016/j.acuro.2016.02.008. Epub 2016 May 13. English, Spanish.

5.

Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML.

J Urol. 2007 Sep;178(3 Pt 1):864-70; discussion 870-1. Epub 2007 Jul 16.

PMID:
17631342
6.

Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.

Daneshmand S, Quek ML, Stein JP, Lieskovsky G, Cai J, Pinski J, Skinner EC, Skinner DG.

J Urol. 2004 Dec;172(6 Pt 1):2252-5.

PMID:
15538242
7.

Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.

Lughezzani G, Gallina A, Larcher A, Briganti A, Capitanio U, Suardi N, Lista G, Abrate A, Sangalli MN, Buffi N, Cestari A, Guazzoni G, Rigatti P, Montorsi F.

BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.

8.

Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.

Preisser F, Nazzani S, Bandini M, Marchioni M, Tian Z, Saad F, Chun FK, Shariat SF, Montorsi F, Huland H, Graefen M, Tilki D, Karakiewicz PI.

Int J Urol. 2018 Nov;25(11):929-936. doi: 10.1111/iju.13780. Epub 2018 Aug 26.

9.

Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis.

Kim KH, Lim SK, Kim HY, Shin TY, Lee JY, Choi YD, Chung BH, Hong SJ, Rha KH.

BJU Int. 2013 Jul;112(2):216-23. doi: 10.1111/j.1464-410X.2012.11765.x. Epub 2013 Jan 29.

10.

Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.

Wenger H, Weiner AB, Razmaria A, Paner GP, Eggener SE.

Urol Oncol. 2017 Jan;35(1):31.e1-31.e6. doi: 10.1016/j.urolonc.2016.08.004. Epub 2016 Sep 28.

PMID:
27692833
11.

Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.

Touijer KA, Mazzola CR, Sjoberg DD, Scardino PT, Eastham JA.

Eur Urol. 2014 Jan;65(1):20-5. doi: 10.1016/j.eururo.2013.03.053. Epub 2013 Apr 10.

PMID:
23619390
12.

The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.

DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML.

J Urol. 2005 Apr;173(4):1121-5.

PMID:
15758719
13.

Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy.

von Bodman C, Godoy G, Chade DC, Cronin A, Tafe LJ, Fine SW, Laudone V, Scardino PT, Eastham JA.

J Urol. 2010 Jul;184(1):143-8. doi: 10.1016/j.juro.2010.03.039. Epub 2010 May 15.

14.

Nondissection of pelvic lymph nodes does not influence the results of perineal radical prostatectomy in selected patients.

Salomon L, Hoznek A, Lefrère-Belda MA, Bellot J, Chopin DK, Abbou CC.

Eur Urol. 2000 Mar;37(3):297-300.

PMID:
10720855
15.

Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.

Palapattu GS, Allaf ME, Trock BJ, Epstein JI, Walsh PC.

J Urol. 2004 Nov;172(5 Pt 1):1860-4.

PMID:
15540739
16.

Pathological features of lymph node metastasis for predicting biochemical recurrence after radical prostatectomy for prostate cancer.

Carlsson SV, Tafe LJ, Chade DC, Sjoberg DD, Passoni N, Shariat SF, Eastham J, Scardino PT, Fine SW, Touijer KA.

J Urol. 2013 Apr;189(4):1314-8. doi: 10.1016/j.juro.2012.10.027. Epub 2012 Oct 22.

17.

Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup.

Moschini M, Sharma V, Zattoni F, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Kwon ED, Karnes RJ.

J Urol. 2016 Jun;195(6):1773-8. doi: 10.1016/j.juro.2015.12.074. Epub 2015 Dec 23.

PMID:
26723866
18.

[Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population].

Hautmann S, Beitz S, Naumann M, Lützen U, Seif C, Stübinger SH, van der Horst C, Braun PM, Leuschner I, Henze E, Jünemann KP.

Urologe A. 2008 Mar;47(3):299-303. doi: 10.1007/s00120-008-1652-2. German.

PMID:
18273596
19.

Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer After Radical Prostatectomy.

Moschini M, Sharma V, Zattoni F, Quevedo JF, Davis BJ, Kwon E, Karnes RJ.

Eur Urol. 2016 Jan;69(1):135-42. doi: 10.1016/j.eururo.2015.03.036. Epub 2015 Apr 10.

PMID:
25865061
20.

Effect of Gleason scores of lymph node metastases on prognosis of patients with prostate cancer.

Ko K, Jeong IG, Choi WS, Lim JH, Suh JH, Ku JH, Park Y, Moon KC, Kim HH, Kim CS, Kwak C.

Int J Clin Exp Pathol. 2014 Aug 15;7(9):6141-8. eCollection 2014.

Supplemental Content

Support Center